Literature DB >> 18669615

ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair.

Cecelia C Yates1, Diana Whaley, Amy Y-Chen, Priya Kulesekaran, Patricia A Hebda, Alan Wells.   

Abstract

In skin wounds, the chemokine CXCR3 receptor appears to play a key role in coordinating the switch from regeneration of the ontogenically distinct mesenchymal and epithelial compartments toward maturation. However, because CXCR3 equivalently binds four different ELR-devoid CXC chemokines (ie, PF4/CXCL4, IP-10/CXCL10, MIG/CXCL9, and IP-9/CXCL11), we sought to identify the ligand that coordinates epidermal coverage with the maturation of the underlying superficial dermis. Because CXCL11 (IP-9 or I-TAC) is produced by redifferentiating keratinocytes late in the regenerative phase when re-epithelialization is completed and matrix maturation ensues, we generated mice in which an antisense construct (IP-9AS) eliminated IP-9 expression during the wound-healing process. Both full and partial thickness excisional wounds were created and analyzed histologically throughout a 2-month period. Wound healing was impaired in the IP-9AS mice, with a hypercellular and immature dermis noted even after 60 days. Re-epithelialization was delayed with a deficient delineating basement membrane persisting in mice expressing the IP-9AS construct. Provisional matrix components persisted in the dermis, and the mature basement membrane components laminin V and collagen IV were severely diminished. Interestingly, the inflammatory response was not diminished despite IP-9/I-TAC being chemotactic for such cells. We conclude that IP-9 is a key ligand in the CXCR3 signaling system for wound repair, promoting re-epithelialization and modulating the maturation of the superficial dermis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669615      PMCID: PMC2527079          DOI: 10.2353/ajpath.2008.070990

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain.

Authors:  Hidenori Shiraha; Angela Glading; Jeffrey Chou; Zongchao Jia; Alan Wells
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.

Authors:  P Proost; E Schutyser; P Menten; S Struyf; A Wuyts; G Opdenakker; M Detheux; M Parmentier; C Durinx; A M Lambeir; J Neyts; S Liekens; P C Maudgal; A Billiau; J Van Damme
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

3.  Epidermal growth factor induces acute matrix contraction and subsequent calpain-modulated relaxation.

Authors:  Fred D Allen; Clara F Asnes; Philip Chang; Elliot L Elson; Douglas A Lauffenburger; Alan Wells
Journal:  Wound Repair Regen       Date:  2002 Jan-Feb       Impact factor: 3.617

4.  Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation.

Authors:  J Flier; D M Boorsma; P J van Beek; C Nieboer; T J Stoof; R Willemze; C P Tensen
Journal:  J Pathol       Date:  2001-08       Impact factor: 7.996

5.  CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma.

Authors:  T Jinquan; S Quan; H H Jacobi; C Jing; A Millner; B Jensen; H O Madsen; L P Ryder; A Svejgaard; H J Malling; P S Skov; L K Poulsen
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

6.  Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair.

Authors:  Latha Satish; Dorne Yager; Alan Wells
Journal:  J Invest Dermatol       Date:  2003-06       Impact factor: 8.551

7.  Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis.

Authors:  T Yamamoto; T Chikugo; Y Tanaka
Journal:  Clin Rheumatol       Date:  2002-11       Impact factor: 2.980

8.  Absence of inhibition of cutaneous wound healing in mice by oral doxycycline.

Authors:  Patricia A Hebda; Diana Whaley; Hyung-Gyoon Kim; Alan Wells
Journal:  Wound Repair Regen       Date:  2003 Sep-Oct       Impact factor: 3.617

9.  Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Authors:  W W Hancock; B Lu; W Gao; V Csizmadia; K Faia; J A King; S T Smiley; M Ling; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  34 in total

1.  Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Michael Czaplik; Yu-Mi Ryang; Markus Kipp; Rolf Rossaint; Cordian Beyer
Journal:  Inflamm Res       Date:  2010-11-23       Impact factor: 4.575

2.  m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate.

Authors:  Ludovic Leloup; Hanshuang Shao; Yong Ho Bae; Bridget Deasy; Donna Stolz; Partha Roy; Alan Wells
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 3.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 4.  The Role of Chemokines in Fibrotic Wound Healing.

Authors:  Jie Ding; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 5.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

Review 6.  Skin wound healing and scarring: fetal wounds and regenerative restitution.

Authors:  Cecelia C Yates; Patricia Hebda; Alan Wells
Journal:  Birth Defects Res C Embryo Today       Date:  2012-12

7.  Can scarring be turned off?

Authors:  Jeffrey M Davidson
Journal:  Am J Pathol       Date:  2010-02-25       Impact factor: 4.307

8.  CXCL11 Expression by Keratinocytes Occurs Transiently Between Reaching Confluence and Cellular Compaction.

Authors:  Arthur C Huen; Archana Marathi; Peter K Nam; Alan Wells
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-12-01       Impact factor: 4.730

Review 9.  The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing.

Authors:  Arthur C Huen; Alan Wells
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

10.  CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Stephanie S Cush; James Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.